237 related articles for article (PubMed ID: 24465642)
1. Chronic proliferative dermatitis in Sharpin null mice: development of an autoinflammatory disease in the absence of B and T lymphocytes and IL4/IL13 signaling.
Potter CS; Wang Z; Silva KA; Kennedy VE; Stearns TM; Burzenski L; Shultz LD; Hogenesch H; Sundberg JP
PLoS One; 2014; 9(1):e85666. PubMed ID: 24465642
[TBL] [Abstract][Full Text] [Related]
2. Integrin beta 1 inhibition alleviates the chronic hyperproliferative dermatitis phenotype of SHARPIN-deficient mice.
Peuhu E; Salomaa SI; De Franceschi N; Potter CS; Sundberg JP; Pouwels J
PLoS One; 2017; 12(10):e0186628. PubMed ID: 29040328
[TBL] [Abstract][Full Text] [Related]
3. Anti-IL5 decreases the number of eosinophils but not the severity of dermatitis in Sharpin-deficient mice.
Renninger ML; Seymour RE; Whiteley LO; Sundberg JP; Hogenesch H
Exp Dermatol; 2010 Mar; 19(3):252-8. PubMed ID: 19650867
[TBL] [Abstract][Full Text] [Related]
4. The pathogenesis of chronic eosinophilic esophagitis in SHARPIN-deficient mice.
Chien SJ; Silva KA; Kennedy VE; HogenEsch H; Sundberg JP
Exp Mol Pathol; 2015 Dec; 99(3):460-7. PubMed ID: 26321245
[TBL] [Abstract][Full Text] [Related]
5. Innate immune adaptor MyD88 deficiency prevents skin inflammation in SHARPIN-deficient mice.
Sharma BR; Karki R; Lee E; Zhu Q; Gurung P; Kanneganti TD
Cell Death Differ; 2019 Mar; 26(4):741-750. PubMed ID: 30038386
[TBL] [Abstract][Full Text] [Related]
6. Distinct role of IL-1β in instigating disease in Sharpin
Gurung P; Sharma BR; Kanneganti TD
Sci Rep; 2016 Nov; 6():36634. PubMed ID: 27892465
[TBL] [Abstract][Full Text] [Related]
7. SHARPIN regulates mitochondria-dependent apoptosis in keratinocytes.
Liang Y; Sundberg JP
J Dermatol Sci; 2011 Sep; 63(3):148-53. PubMed ID: 21620685
[TBL] [Abstract][Full Text] [Related]
8. The Inflammatory Caspases-1 and -11 Mediate the Pathogenesis of Dermatitis in Sharpin-Deficient Mice.
Douglas T; Champagne C; Morizot A; Lapointe JM; Saleh M
J Immunol; 2015 Sep; 195(5):2365-73. PubMed ID: 26216893
[TBL] [Abstract][Full Text] [Related]
9. Keratinocyte-specific deletion of SHARPIN induces atopic dermatitis-like inflammation in mice.
Sundberg JP; Pratt CH; Goodwin LP; Silva KA; Kennedy VE; Potter CS; Dunham A; Sundberg BA; HogenEsch H
PLoS One; 2020; 15(7):e0235295. PubMed ID: 32687504
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of NF-κB signaling retards eosinophilic dermatitis in SHARPIN-deficient mice.
Liang Y; Seymour RE; Sundberg JP
J Invest Dermatol; 2011 Jan; 131(1):141-9. PubMed ID: 20811394
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous mutations in the mouse Sharpin gene result in multiorgan inflammation, immune system dysregulation and dermatitis.
Seymour RE; Hasham MG; Cox GA; Shultz LD; Hogenesch H; Roopenian DC; Sundberg JP
Genes Immun; 2007 Jul; 8(5):416-21. PubMed ID: 17538631
[TBL] [Abstract][Full Text] [Related]
12.
Siitonen R; Peuhu E; Autio A; Liljenbäck H; Mattila E; Metsälä O; Käkelä M; Saanijoki T; Dijkgraaf I; Jalkanen S; Ivaska J; Roivainen A
J Nucl Med; 2019 Oct; 60(10):1380-1387. PubMed ID: 30850498
[TBL] [Abstract][Full Text] [Related]
13. Sharpin prevents skin inflammation by inhibiting TNFR1-induced keratinocyte apoptosis.
Kumari S; Redouane Y; Lopez-Mosqueda J; Shiraishi R; Romanowska M; Lutzmayer S; Kuiper J; Martinez C; Dikic I; Pasparakis M; Ikeda F
Elife; 2014 Dec; 3():. PubMed ID: 25443631
[TBL] [Abstract][Full Text] [Related]
14. Immune dysregulation in SHARPIN-deficient mice is dependent on CYLD-mediated cell death.
Ang RL; Chan M; Legarda D; Sundberg JP; Sun SC; Gillespie VL; Chun N; Heeger PS; Xiong H; Lira SA; Ting AT
Proc Natl Acad Sci U S A; 2021 Dec; 118(50):. PubMed ID: 34887354
[TBL] [Abstract][Full Text] [Related]
15. Accumulation and activation of epidermal γδ T cells in a mouse model of chronic dermatitis is not required for the inflammatory phenotype.
Sulcova J; Maddaluno L; Meyer M; Werner S
Eur J Immunol; 2015 Sep; 45(9):2517-28. PubMed ID: 26081170
[TBL] [Abstract][Full Text] [Related]
16. Sharpin Controls Osteogenic Differentiation of Mesenchymal Bone Marrow Cells.
Jeschke A; Catala-Lehnen P; Sieber S; Bickert T; Schweizer M; Koehne T; Wintges K; Marshall RP; Mautner A; Duchstein L; Otto B; Horst AK; Amling M; Kreienkamp HJ; Schinke T
J Immunol; 2015 Oct; 195(8):3675-84. PubMed ID: 26363054
[TBL] [Abstract][Full Text] [Related]
17. SHARPIN is a key regulator of immune and inflammatory responses.
Wang Z; Potter CS; Sundberg JP; Hogenesch H
J Cell Mol Med; 2012 Oct; 16(10):2271-9. PubMed ID: 22452937
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis in the skin of SHARPIN-deficient mice with chronic proliferative dermatitis.
HogenEsch H; Sola M; Stearns TM; Silva KA; Kennedy VE; Sundberg JP
Exp Mol Pathol; 2016 Dec; 101(3):303-307. PubMed ID: 27794420
[TBL] [Abstract][Full Text] [Related]
19. Expression of chitinase-like proteins in the skin of chronic proliferative dermatitis (cpdm/cpdm) mice.
HogenEsch H; Dunham A; Seymour R; Renninger M; Sundberg JP
Exp Dermatol; 2006 Oct; 15(10):808-14. PubMed ID: 16984263
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of type 2 cytokines in chronic proliferative dermatitis (cpdm) mutant mice and resolution of inflammation following treatment with IL-12.
HogenEsch H; Torregrosa SE; Boggess D; Sundberg BA; Carroll J; Sundberg JP
Eur J Immunol; 2001 Mar; 31(3):734-42. PubMed ID: 11241277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
